Elan to Present at the Morgan Stanley Pharmaceutical CEO's Unplugged

    Business Editors/Biotech Writers
    Morgan Stanley Pharmaceutical CEO's Unplugged Conference

    DUBLIN, Ireland--(BUSINESS WIRE)--Jan. 4, 2005--Elan Corporation, plc announces that it will present at the Morgan Stanley Pharmaceutical CEO's Unplugged Conference in New York on Thursday, January 6, 2005 at 8:45 a.m. Eastern Standard Time, 1:45 p.m. Greenwich Mean Time. Interested parties may access a live audio webcast of the presentation by visiting Elan's website at www.elan.com and clicking on the Investor Relations section, then on the event icon.

    About Elan

    Elan is a neuroscience-based biotechnology company that is focused on discovering, developing, manufacturing, selling and marketing advanced therapies in neurodegenerative diseases, autoimmune diseases and severe pain. Elan's (NYSE: ELN) shares trade on the New York, London and Dublin Stock Exchanges.

--30--IS/ny*

CONTACT: Elan Corporation, plc Investors: Emer Reynolds, 353-1-709-4000 / 800-252-3526 or Media: Anita Kawatra, 212-407-5740 / 800-252-3526

KEYWORD: NEW YORK IRELAND INTERNATIONAL EUROPE INDUSTRY KEYWORD: MEDICAL PHARMACEUTICAL BIOTECHNOLOGY TRADESHOW SOURCE: Elan Corporation, plc

Copyright Business Wire 2005